
On June 26, 2025, in order to get acquainted with the infrastructure and production capacity of the plant, as well as to discuss issues of bilateral cooperation, regional representative of the French transnational pharmaceutical company Sanofi Anokhin Alexander Sergeyevich visited the biopharmaceutical plant OtarBioPharm LLP.

On June 23, 2025, Frank Wu, founder and other specialists of Shanghai United Cell Biotech (PRC) – an international biopharmaceutical company that combines the entire production cycle of high-quality innovative and generic biological drugs: from research and development to production, as well as representatives of NN INVEST (RK), which provides consulting services to foreign companies in the markets of Kazakhstan and Central Asia visited the OtarBioPharm LLP biopharmaceutical plant to inspect the biopharmaceutical plant to explore the possibility of cooperation.

On June 20, 2025, representatives of companies from Mongolia - Director of GDP VetLand Dorjbat Uuganbayar, Director of Tenuunkhishig Ganjuur Khishigjargal, Mongolia, and Chief Veterinarian-Manager of Mongolia Kadyei Zurash accompanied by the General Director and other officials of QazBioPharm National Holding JSC visited the biopharmaceutical plant of OtarBioPharm LLP in order to get acquainted with the activities of the plant and discuss the possibility of cooperation.

On May 15-16, 2025, the employees of the Partnership took part in the exhibition and international conference "120 years of Kazakh veterinary science: achievements and new challenges in ensuring biological safety", dedicated to the 120th anniversary of the Kazakh Research Veterinary Institute.

On February 12, 2025, the Akimat of the Otar rural district organized an open volleyball tournament dedicated to "February 15 – the 36th anniversary of the withdrawal of Soviet troops from Afghanistan."

On January 29, 2025, the 1st (for 2025) meeting of the members of the Scientific and Technical Council of the Partnership was held.
On November 18, 2024, production of big cattle, small ruminants and pigs Foot-And-Mouth disease vaccine was launched at the biopharmaceutical plant of OtarBioPharm LLP as part of the technology transfer. Foreign technologists from Boehringer Ingelheim Animal Health, France, who arrived at the biopharmaceutical plant in order to assess the compliance of vaccine production […]
Today, the Partnership has once again received confirmation of the compliance of the conditions created at the biopharmaceutical plant with the requirements of the standard of Good Manufacturing practices (GMP) – the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan issued a Certificate of compliance of the […]
On July 29, 2024, the OtarBioPharm biopharmaceutical plant was visited by Sultangaziyev T.S. – First Vice-Minister of Health of the Republic of Kazakhstan, Ahmed-Zaki D.Zh. – Vice-Minister of Science and Higher Education of the Republic of Kazakhstan, Kalenderov N.S. – First Deputy Akim of Zhambyl region, Sadvakasov N.O. – Chairman of the Committee of Sanitary […]
On April 09-10, 2024, Director for General Affairs A. Satybaldiyev, Head of the Production Unit D. Kaysenov, Leading Equipment Engineer D. Shulenbayev and press secretary A. Kaltayev took part in the 2nd International Congress and Exhibition «Pharma Kazakhstan and Central Asia» in Almaty, organized by Vostoc Capital, which brought together more than 200 representatives of […]
If the main stream of workers employed at the first production complex of the plant, built on direct instructions of the President of the Republic of Kazakhstan K.K. Tokayev, are experienced scientists, specialists from a research institute who can conduct their own work, then, to the 2nd complex of the biopharmaceutical plant it is planned […]